| Press Release

BluMaiden Biosciences Pte Ltd
Three Shenton Way #15-01
Singapore 068605
T (65) 9720 0753
www.blumaiden.com

02 August 2021

 

 

Professor Kim Lewis

 

Director

Antimicrobial Discovery Center Northeastern University

 

Scientific Advisory Board

BluMaiden Biosciences

Professor Kim Lewis – Professor Kim Lewis is a Scientific Advisory Board member at BluMaiden Biosciences. Currently he is a University Distinguished Professor and the Director of Antimicrobial Discovery Center at Northeastern University in Boston, Massachusetts.

Formally he held faculty appointments at Massachusetts Institute of Technology, University of Maryland and Tufts University. A distinguished molecular microbiologist whose research career has focused on the mechanisms of antimicrobial resistance, Lewis is a Fellow of the American Association for the Advancement of Science and a Fellow of the American Acade- my of Microbiology.

 

Lewis’ research has resolved key problems underpinning the mechanisms by which bacteria can resist the action of antibiotics, discovered new classes of antibiotics and demonstrated the potential of finding antibiotic compounds in microbiomes. Lewis has a long-standing engagement with the biotech industry and pharma. At BluMaiden Biosciences, he is guiding the scientific team on approaches for discovering new therapeutic compounds from human microbiomes.

About BluMaiden Biosciences
BluMaiden Biosciences is an early-stage biotechnology company headquartered in Singapore with the goal of developing microbiome-derived molecular
therapeutics for patients with unmet medical needs. We have integrated a unique computational population-scale data acquisition platform with a therapeutics discovery platform.
Contact Information
BluMaiden Biociences Pte Ltd
enquires@blumaiden.com

Get In Touch

Whether you are a medical practitioner, a patient or would like to learn more, we would love to hear from you

Share this Article